NextCure (NXTC) Operating Expenses (2018 - 2026)

NextCure's Operating Expenses history runs 9 years deep, the most recent figure standing at $10.1 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 13.05% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $56.1 million (up 5.72% YoY), while the FY2025 annual figure was $57.6 million, down 3.57% from the prior year.
• Operating Expenses for Q1 2026 stood at $10.1 million, up from $9.8 million in the prior quarter.
• The five-year high for Operating Expenses was $27.3 million in Q2 2025, with the low at $8.9 million in Q3 2025.
• The 5-year median for Operating Expenses is $16.5 million (2024), against an average of $15.9 million.
• Peak annual rise in Operating Expenses reached 65.47% in 2025, while the deepest fall reached 36.51% in 2025.
• NextCure's Operating Expenses stood at $17.8 million in 2022, then dropped by 11.15% to $15.8 million in 2023, then decreased by 21.12% to $12.5 million in 2024, then retreated by 21.66% to $9.8 million in 2025, then rose by 3.57% to $10.1 million in 2026.
• Business Quant data shows NXTC's Operating Expenses at $10.1 million in Q1 2026, $9.8 million in Q4 2025, and $8.9 million in Q3 2025.